loading...| Preferred Name |
estropipate |
|
| Synonyms |
estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. with piperazine (1:1) |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C009927 |
|
| altLabel |
estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. with piperazine (1:1) Genoral piperazine estrone sulfate Harmogen Harmonet Ogen Ortho-Est |
|
| cui |
C1530056 C0722236 C4759688 C0722326 C0071108 C0120758 |
|
| Has mapping qualifier | ||
| HM |
D004970/Q000031 |
|
| II |
D004966 |
|
| Inverse of RB |
0 SVI38UY019 |
|
| isa | ||
| LT |
TRD |
|
| Mapped to | ||
| MDA |
19750101 |
|
| MeSH Frequency |
58 |
|
| MMR |
20190524 |
|
| notation |
C009927 |
|
| PA |
D000080066 |
|
| PI |
PIPERAZINES (75-82) |
|
| prefLabel |
estropipate |
|
| RR |
7280-37-7 (estropipate) |
|
| SC |
1 |
|
| Scope Statement |
used therapeutically in menopausal patients |
|
| SRC |
Practitioner 218(1306):573;1977 Curr Med Res Opin 4(4):303;1976 Curr Med Res Opin 2(7):417;1974 IARC Monogr Eval Carcinog Risk Chem Hum1979;21:147 |
|
| TERMUI |
T085029 T085026 T624150 T000952698 T085027 T085028 T624146 T624148 |
|
| TH |
US MX UK CA NLM (2020) NLM (1975) INN (19XX) AU FDA SRS (2015) USAN (1975) IE |
|
| tui |
T125 T109 T121 |